McKesson (MCK) Stock Price
McKesson Price
Revenue has compounded at 8.0% per year over the past 19 years to 403.43 B USD. Earnings per share have grown at 14.1% per year over the last 19 years. McKesson's net margin stands at 1.2%, broadly stable from 0.4% several years earlier. McKesson currently offers a dividend yield of about 0.35%. The payout ratio is around 10% of earnings. The dividend has grown at 14.5% per year over the past 19 years. Analysts set a median price target of 992.50 USD, implying 9.2% above the current price. Of 24 analysts, 19 rate the stock a buy — an overall Buy consensus.
McKesson stock price
McKesson business model & stock analysis
Frequently asked questions about McKesson
The business model of Mckesson Corp is centered around being a leading healthcare services and information technology company. Mckesson Corp provides various solutions to healthcare organizations including pharmaceuticals distribution, medical-surgical distribution, and healthcare technology. With a wide network and expertise in supply chain management, Mckesson Corp ensures the efficient distribution of pharmaceuticals and medical products to healthcare providers, helping them deliver quality patient care. Through its technology solutions and analytics, Mckesson Corp also supports healthcare organizations in managing their operations, improving clinical outcomes, and optimizing financial performance. This comprehensive approach enables Mckesson Corp to drive innovation and provide value across the healthcare industry.
Mckesson Corp is primarily active in the healthcare and pharmaceutical industries.
The main competitors of Mckesson Corp in the market include Cardinal Health, AmerisourceBergen, and Owens & Minor.
McKesson Corp is a leading global healthcare company that has a rich history and extensive background. Founded in 1833 by John McKesson and Charles Olcott, the company initially operated as a pharmaceutical wholesaler. Over the years, McKesson Corp has expanded its operations and diversified its services. Today, it provides innovative healthcare solutions and advanced technologies to improve patient care and drive efficiency in the industry. With a focus on pharmaceutical distribution, medical supplies, technologies, and healthcare business solutions, McKesson Corp has become a trusted name in the healthcare sector. The company's commitment to delivering quality healthcare solutions has firmly established its position as a key player in the industry.
McKesson Corp, a leading healthcare services and pharmaceutical distribution company, has achieved several significant milestones throughout its history. One notable achievement was the company's inclusion in the Fortune 500 list, a prestigious ranking of the largest US corporations. Additionally, McKesson's acquisition of several notable companies, such as Celesio AG and PSS World Medical Inc., have expanded its market presence and strengthened its position in the industry. Furthermore, the company has consistently delivered strong financial performance and demonstrated its commitment to innovation and technological advancements in healthcare. McKesson Corp continues to strive for excellence, making it a reliable and trusted partner in the healthcare sector.
Mckesson Corp is primarily present in the United States.
Mckesson Corp represents a strong set of values and a clear corporate philosophy. The company prioritizes integrity, teamwork, and customer-driven thinking. Mckesson Corp strives for excellence in all its endeavors, placing a strong emphasis on ethical conduct and transparency. With a focus on delivering innovative healthcare solutions, Mckesson Corp aims to improve patient care and drive positive change in the industry. The company's commitment to diversity and inclusion is also evident in its corporate philosophy. Mckesson Corp remains dedicated to providing quality products and services while upholding its core values to benefit both customers and the healthcare community.
Analysts currently set an average price target of 988.00 USD for the McKesson stock (median: 992.50 USD), implying +8.7 % versus the latest price. The consensus is based on 24 analyst ratings.
24 analysts currently rate the McKesson stock: 19 recommend buying, 5 holding and 0 selling.
Converted at the current exchange rate, the McKesson share trades at 810.90 EUR (908.97 USD).
The McKesson share (MCK) is listed on 7 stock exchanges, including: NYSE (MCK), London (0JZU.L), SIX (Zürich) (MCK.SW), Frankfurt (MCK.F), München (MCK.MU), Düsseldorf (MCK.DU).
Mckesson Corp is a US-based healthcare company that offers a wide range of products and services for the healthcare industry. The company was founded in 1833 as a pharmacy operation and has evolved into a diverse company over the years. Today, Mckesson Corp is one of the largest healthcare companies in the world with an annual revenue of over $231 billion.
The revenue of McKesson is 403.43 B USD. This figure is based on current financial data and reflects the company's business performance.
The profit of McKesson is 4.76 B USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of McKesson is currently 22.75. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the McKesson stock.
The price-to-sales ratio (P/S) of McKesson is currently 0.27. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the McKesson stock.
The Eulerpool Quality Score for McKesson is 6/10.
The ISIN of McKesson is US58155Q1031. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of McKesson is 893953. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of McKesson is MCK. The ticker symbol is used to trade McKesson shares on the stock exchange.
McKesson stock
McKesson Peer Group
McKesson Ticker
McKesson FIGI
All fundamentals and in-depth analysis of McKesson
Our stock analysis for McKesson stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of McKesson. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.